{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:15:59Z","timestamp":1777328159428,"version":"3.51.4"},"publisher-location":"Cham","reference-count":22,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319100142","type":"print"},{"value":"9783319100159","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/5584_2014_28","type":"book-chapter","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T15:16:56Z","timestamp":1411571816000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Classical Against Molecular-Genetic Methods for Susceptibility Testing of Antituberculotics"],"prefix":"10.1007","author":[{"given":"I.","family":"Porvaznik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mokry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Solovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"key":"28_CR1","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1128\/AAC.41.10.2270","volume":"41","author":"F Alcaide","year":"1997","unstructured":"Alcaide F, Pfyffer GE, Telenti A (1997) Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother 41:2270\u20132273","journal-title":"Antimicrob Agents Chemother"},{"key":"28_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1128\/AAC.48.4.1281-1288.2004","volume":"48","author":"A Aubry","year":"2004","unstructured":"Aubry A, Pan XS, Fisher LM, Jarlier V, Cambau E (2004) Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity. Antimicrob Agents Chemother 48:1281\u20131288","journal-title":"Antimicrob Agents Chemother"},{"key":"28_CR3","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1128\/JCM.39.10.3736-3739.2001","volume":"39","author":"Z Bartfai","year":"2001","unstructured":"Bartfai Z, Somoskovi A, Kodmon C, Szabo N, Puskas E, Kosztolanyi L, Farago E, Mester J, Parsons LM, Salfinger M (2001) Molecular characterisation of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 39:3736\u20133739","journal-title":"J Clin Microbiol"},{"key":"28_CR4","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1128\/JCM.01054-06","volume":"44","author":"F Brossier","year":"2006","unstructured":"Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W (2006) Performance of the Genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol 44:3659\u20133664","journal-title":"J Clin Microbiol"},{"key":"28_CR22","unstructured":"Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA (1969) Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 41(1):21\u201343"},{"key":"28_CR5","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.3201\/eid1811.120526","volume":"18","author":"P Cegielski","year":"2012","unstructured":"Cegielski P, Nunn P, Kurbatova EV, Weyer K, Dalton TL, Wares DF, Iademarco MF, Castro KG, Raviglione M (2012) Challenges and controversies in defining totally drug-resistant tuberculosis. Emerg Infect Dis 18:e2. doi:10.3201\/eid1811.120526","journal-title":"Emerg Infect Dis"},{"key":"28_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1369-5274(99)00008-9","volume":"2","author":"K Drlica","year":"1999","unstructured":"Drlica K (1999) Mechanism of fluoroquinolone action. Curr Opin Microbiol 2:504\u2013508","journal-title":"Curr Opin Microbiol"},{"key":"28_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1099\/00222615-47-3-189","volume":"47","author":"FA Drobniewski","year":"1998","unstructured":"Drobniewski FA, Wilson SM (1998) The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis \u2013 a molecular story. J Med Microbiol 47:189\u2013196","journal-title":"J Med Microbiol"},{"key":"28_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/AAC.46.2.267-274.2002","volume":"46","author":"SH Gillespie","year":"2002","unstructured":"Gillespie SH (2002) Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother 46:267\u2013274","journal-title":"Antimicrob Agents Chemother"},{"key":"28_CR9","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1128\/AAC.00851-09","volume":"53","author":"L Jugheli","year":"2009","unstructured":"Jugheli L, Bzekalava N, de Rijk P, Fissette K, Portaels F, Rigouts L (2009) High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob Agents Chemother 53:5064\u20135068","journal-title":"Antimicrob Agents Chemother"},{"key":"28_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1183\/09031936.05.00111304","volume":"25","author":"SJ Kim","year":"2005","unstructured":"Kim SJ (2005) Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J 25:564\u2013569","journal-title":"Eur Respir J"},{"key":"28_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1128\/JCM.01066-07","volume":"46","author":"P Miotto","year":"2008","unstructured":"Miotto P, Piana F, Penati V, Canducci F, Migliori GB (2008) Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 46:393\u2013394","journal-title":"J Clin Microbiol"},{"key":"28_CR21","unstructured":"NRT (2012) http:\/\/int.vhagy.sk\/hagy\/?q=narodny-register-tbc"},{"key":"28_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1099\/jmm.0.037614-0","volume":"61","author":"YK Park","year":"2012","unstructured":"Park YK, Ryoo SW, Lee SH, Jnwali HN, Kim C, Kim HJ, Kim SJ (2012) Correlation of the phenotypic ethambutol susceptibility of Mycobacterium tuberculosis with embB gene mutations in Korea. J Med Microbiol 61:529\u2013534","journal-title":"J Med Microbiol"},{"key":"28_CR13","first-page":"42","volume":"3","author":"L Rabarijaona","year":"1999","unstructured":"Rabarijaona L, Boisier P, Ratsirahonana O, Razafinimanana J, Rakotomanana F, Ratsitorahina M, Ramarokoto H, Cauchoix B, Aur\u00e9gan G (1999) Replacement of streptomycin by ethambutol in the intensive phase of tuberculosis treatment: no effect on compliance. Int J Tuberc Lung Dis 3:42\u201346","journal-title":"Int J Tuberc Lung Dis"},{"key":"28_CR14","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1183\/09031936.00145411","volume":"39","author":"A Skrahina","year":"2012","unstructured":"Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, van Gemert W, Hoffner S, Rusovich V, Zignol M (2012) Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk. Eur Respir J 39:1425\u20131431","journal-title":"Eur Respir J"},{"key":"28_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0140-6736(93)90417-F","volume":"341","author":"A Telenti","year":"1993","unstructured":"Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, Bodmer T (1993) Detection of rifampicin resistance mutations in Mycobacterium tuberculosis. Lancet 341:647\u2013650","journal-title":"Lancet"},{"key":"28_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nm0597-567","volume":"3","author":"A Telenti","year":"1997","unstructured":"Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, Musser JM, Jacobs WR Jr (1997) The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3:567\u2013570","journal-title":"Nat Med"},{"key":"28_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1099\/00221287-88-2-269","volume":"88","author":"M Tsukamura","year":"1975","unstructured":"Tsukamura M, Mizuno S (1975) Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis. J Gen Microbiol 88:269\u2013274","journal-title":"J Gen Microbiol"},{"key":"28_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.5588\/ijtld.11.0605","volume":"16","author":"MJ Van der Werf","year":"2012","unstructured":"Van der Werf MJ, Sandgren A, Manissero D (2012) Management of contacts of multidrug-resistant tuberculosis patients in the European Union and European Economic Area. Int J Tuberc Lung Dis 16:426","journal-title":"Int J Tuberc Lung Dis"},{"key":"28_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0140-6736(00)02429-6","volume":"356","author":"A Van Rie","year":"2000","unstructured":"Van Rie A, Warren R, Richardson M, Gie RP, Enarson DA, Beyers N, Van Helden PD (2000) Classification of drug-resistant tuberculosis in an epidemic area. Lancet 356:22\u201325","journal-title":"Lancet"},{"key":"28_CR20","first-page":"1","volume-title":"Treatment of tuberculosis. Guidelines for the management of drug-resistant tuberculosis","author":"WHO","year":"1997","unstructured":"WHO (1997) Treatment of tuberculosis. Guidelines for the management of drug-resistant tuberculosis, 2nd edn. World Health Organization, Geneva, pp 1\u201347","edition":"2"}],"container-title":["Advances in Experimental Medicine and Biology","Respiratory Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2014_28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T22:06:40Z","timestamp":1676585200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/5584_2014_28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783319100142","9783319100159"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/5584_2014_28","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"25 September 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}